Subject: AEPP Announces Name Change Ticker Symbol Change Soon to Follow

SCV Client Spotlight
BY READING THIS EMAIL YOU CERTIFY YOU HAVE READ THE DISCLAIMER BELOW AND THE FULL DISCLAIMER PROVIDED THROUGH A LINK AT THE END OF THIS EMAIL. This is a paid advertisement., Inc. is not responsible or held liable for the information in the press releases issued by the companies in these emails. Please always do your own due diligence.
Facebook Twitter YouTube
Name Change Highlights Focus on New Cancer Therapeutics
Hot Stock to WatchHot Stock to Watch

Company: Oncolix, Inc. (Pink Sheets: AEPP)


Price: 0.0584

Change (%): + 0.00 (0.00)

Volume: 0
AEPP Chart

Oncolix, Inc. is the New Name of Advanced Environmental Petroleum Producers to Reflect Company’s Focus as a Clinical-Stage Oncology Biopharmaceutical Company

HOUSTON, Oct. 03, 2017 (GLOBE NEWSWIRE) - (AEPP) Advanced Environmental Petroleum Producers Inc. announced that it has changed its name to Oncolix, Inc., to reflect its focus on developing new cancer therapeutics. The Company will now promptly file a request with the Financial Industry Regulatory Authority (FINRA) to change its stock symbol to be consistent with the new name.

The name change was approved by written consent of the holders of the majority of the voting securities of the Company on August 21, 2017. Furthermore, an information statement pursuant to Regulation 14C of the Securities Exchange Act of 1934, was mailed on September 6, 2017, to holders of record of the Company’s common and preferred stock as of August 21, 2017. The shareholder action became effective on September 27, 2017. The Company then filed an Amendment to its Articles of Incorporation with the Secretary of State of Florida on September 28, 2017.

“This name change reflects our current operating business, which is a drug development company,” stated Michael T. Redman, CEO of Oncolix. “This, along with our forthcoming request for a stock symbol change and other activities that we are engaged in, is part of our ultimate objective of becoming a Nasdaq-listed emerging biopharmaceutical company.”

Continue Reading

Like Us on FacebookFollow Us on Twitter

SmallCapVoice (SCV) is an electronic publication. Information sources for our profiles include, but are not limited to, online research, member suggestions, magazines, newspapers, analyst suggestions, publicly available material information provided by the profiled company, press releases and similar sources. This communication is not an offer to sell or a recommendation that you buy or sell any security. SCV holds no securities licenses and is not qualified to provide investment advice. We are compensated for these advertisements by the profiled companies. You should not use this newsletter as the sole basis for any investment decision. While all investments involve risk, microcap stocks are among the most risky. Many microcap companies have no proven track record. You should only invest in microcap companies if you can afford to lose your entire investment. You should consult a qualified, licensed financial advisor or stock broker before making any decisions to invest in the securities of any company that is described in these profiles. These profiles are paid advertisements. Although we have a reasonable belief that the information in each profile is accurate, we cannot guarantee that this information, which originates from third parties, is accurate. We do not have the resources to confirm the accuracy of all information obtained from third parties. It is important for you to verify all information by your own independent research. You are receiving this message because you have agreed to receive emails from You may opt out of our distribution list at any time by clicking on the “unsubscribe” link below. Link to full disclosure about compensation paid to, Inc. by companies featured on our website or in our e-mail communications.

About Penny Stocks